Despite recent positive returns from Uni-Bio Science Group, the market, as indicated by the P/S ratio, predicts this performance won't last. Current shareholders may remain optimistic, but the consensus appears to believe in continued limited growth rates, hence the devaluation of the stock.
联康生物科技集团股票讨论区
暂无评论